Phase I Clinical Trial of Costimulated, IL-4 Polarized Donor CD4+ T Cells as Augmentation of Allogeneic Hematopoietic Cell Transplantation

Horowitz, 1990, Graft-versus-leukemia reactions after bone marrow transplantation, Blood, 75, 555, 10.1182/blood.V75.3.555.555 Mielcarek, 2003, Graft-versus-host disease after nonmyeloablative versus conventional hematopoietic stem cell transplantation, Blood, 102, 756, 10.1182/blood-2002-08-2628 Kolb, 1995, Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients, Blood, 86, 2041, 10.1182/blood.V86.5.2041.bloodjournal8652041 Schetelig, 2003, Evidence of a graft-versus-leukemia effect in chronic lymphocytic leukemia after reduced-intensity conditioning and allogeneic stem-cell transplantation: the Cooperative German Transplant Study Group, J Clin Oncol, 21, 2747, 10.1200/JCO.2003.12.011 Khouri, 2001, Nonablative allogeneic hematopoietic transplantation as adoptive immunotherapy for indolent lymphoma: low incidence of toxicity, acute graft-versus-host disease, and treatment-related mortality, Blood, 98, 3595, 10.1182/blood.V98.13.3595 Ferrara, 2003, The pathophysiology of acute graft-versus-host disease, Int J Hematol, 78, 181, 10.1007/BF02983793 Fowler, 1994, Cells of Th2 cytokine phenotype prevent LPS-induced lethality during murine graft-versus-host reaction, J Immunol, 152, 1004 Krenger, 1995, Polarized type 2 alloreactive CD4+ and CD8+ donor T cells fail to induce experimental acute graft-versus-host disease, J Immunol, 155, 585 Schwarer, 1993, Frequency of anti-recipient alloreactive helper T-cell precursors in donor blood and graft-versus-host disease after HLA-identical sibling bone-marrow transplantation, Lancet, 341, 203, 10.1016/0140-6736(93)90067-Q Imami, 1998, Association between interleukin-4-producing T lymphocyte frequencies and reduced risk of graft-versus-host disease, Transplantation, 65, 979, 10.1097/00007890-199804150-00019 Levine, 1997, Effects of CD28 costimulation on long-term proliferation of CD4+ T cells in the absence of exogenous feeder cells, J Immunol, 159, 5921 Levine, 1995, CD28 ligands CD80 (B7-1) and CD86 (B7-2) induce long-term autocrine growth of CD4+ T cells and induce similar patterns of cytokine secretion in vitro, Int Immunol, 7, 891, 10.1093/intimm/7.6.891 Levine, 2002, Adoptive transfer of costimulated CD4+ T cells induces expansion of peripheral T cells and decreased CCR5 expression in HIV infection, Nat Med, 8, 47, 10.1038/nm0102-47 Laport, 2003, Adoptive transfer of costimulated T cells induces lymphocytosis in patients with relapsed/refractory non-Hodgkin lymphoma following CD34+-selected hematopoietic cell transplantation, Blood, 102, 2004, 10.1182/blood-2003-01-0095 Rapoport, 2005, Restoration of immunity in lymphopenic individuals with cancer by vaccination and adoptive T-cell transfer, Nat Med, 11, 1230, 10.1038/nm1310 Rapoport, 2004, Molecular remission of CML after autotransplantation followed by adoptive transfer of costimulated autologous T cells, Bone Marrow Transplant, 33, 53, 10.1038/sj.bmt.1704317 Porter, 2006, A phase 1 trial of donor lymphocyte infusions expanded and activated ex vivo via CD3/CD28 costimulation, Blood, 107, 1325, 10.1182/blood-2005-08-3373 Le Gros, 1990, Generation of interleukin 4 (IL-4)-producing cells in vivo and in vitro: IL-2 and IL-4 are required for in vitro generation of IL-4-producing cells, J Exp Med, 172, 921, 10.1084/jem.172.3.921 Bishop, 2003, Establishment of early donor engraftment after reduced-intensity allogeneic hematopoietic stem cell transplantation to potentiate the graft-versus-lymphoma effect against refractory lymphomas, Biol Blood Marrow Transplant, 9, 162, 10.1016/S1083-8791(03)70005-6 Quinones, 1993, Extended-cycle elutriation to adjust T-cell content in HLA-disparate bone marrow transplantation, Blood, 82, 307, 10.1182/blood.V82.1.307.bloodjournal821307 Glucksberg, 1974, Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors, Transplantation, 18, 295, 10.1097/00007890-197410000-00001 Shulman, 1980, Chronic graft-versus-host syndrome in man, Am J Med, 69, 204, 10.1016/0002-9343(80)90380-0 Cheson, 1999, Report of an international workshop to standardize response criteria for non-Hodgkin’s lymphomas, J Clin Oncol, 17, 1244, 10.1200/JCO.1999.17.4.1244 Fowler, 2004, Clinical “cytokine storm” as revealed by monocyte intracellular flow cytometry: correlation of tumor necrosis factor alpha with severe gut graft-versus-host disease, Clin Gastroenterol Hepatol, 2, 237, 10.1016/S1542-3565(04)00011-4 Altman, 1996, Phenotypic analysis of antigen-specific T lymphocytes, Science, 274, 94, 10.1126/science.274.5284.94 Vonderheide, 2001, Equivalent induction of telomerase-specific cytotoxic T lymphocytes from tumor-bearing patients and healthy individuals, Cancer Res, 61, 8366 Schlette, 2004, Survivin expression predicts poorer prognosis in anaplastic large-cell lymphoma, J Clin Oncol, 22, 1682, 10.1200/JCO.2004.10.172 Matsushita, 2003, Preferentially expressed antigen of melanoma (PRAME) in the development of diagnostic and therapeutic methods for hematological malignancies, Leuk Lymphoma, 44, 439, 10.1080/1042819021000035725 Siehl, 2003, Possible regulation of Wilms’ tumour gene 1 (WT1) expression by the paired box genes PAX2 and PAX8 and by the haematopoietic transcription factor GATA-1 in human acute myeloid leukaemias, Br J Haematol, 123, 235, 10.1046/j.1365-2141.2003.04622.x Vonderheide, 2004, Vaccination of cancer patients against telomerase induces functional antitumor CD8+ T lymphocytes, Clin Cancer Res, 10, 828, 10.1158/1078-0432.CCR-0620-3 Bethge, 2003, Relapse or progression after hematopoietic cell transplantation using nonmyeloablative conditioning: effect of interventions on outcome, Exp Hematol, 31, 974, 10.1016/S0301-472X(03)00225-X Spitzer, 2001, Engraftment syndrome following hematopoietic stem cell transplantation, Bone Marrow Transplant, 27, 893, 10.1038/sj.bmt.1703015 Fowler, 1996, Allospecific CD4+, Th1/Th2 and CD8+, Tc1/Tc2 populations in murine GVL: type I cells generate GVL and type II cells abrogate GVL, Biol Blood Marrow Transplant, 2, 118 Deeg, 2000, Cyclosporine (CSP)or CSP plus methylprednisolone for graft-versus-host disease prophylaxis in patients with high-risk lymphohemopoietic malignancies: long-term follow-up of a randomized trial, Blood, 96, 1194, 10.1182/blood.V96.3.1194a Nestel, 1992, Macrophage priming and lipopolysaccharide-triggered release of tumor necrosis factor alpha during graft-versus-host disease, J Exp Med, 175, 405, 10.1084/jem.175.2.405 Lowsky, 2005, Protective conditioning for acute graft-versus-host disease, N Engl J Med, 353, 1321, 10.1056/NEJMoa050642 Foley, 2005, Ex vivo rapamycin generates donor Th2 cells that potently inhibit graft-versus-host disease and graft-versus-tumor effects via an IL-4-dependent mechanism, J Immunol, 175, 5732, 10.4049/jimmunol.175.9.5732 Blazar, 1998, Rapamycin inhibits the generation of graft-versus-host disease- and graft-versus-leukemia-causing T cells by interfering with the production of Th1 or Th1 cytotoxic cytokines, J Immunol, 160, 5355